CPIX

Cumberland Pharmaceuticals Inc

3.120

+0.050+1.63%

Closed16:49 03/30 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE3.120/3.070

TODAY RANGE3.060-3.260

VOL35.93K

MARKET CAP46.66M

52 WEEK RANGE1.850-6.27

AVG VOL (3M)164.06K

% TURNOVER0.24%

TURNOVER216.67M

P/E (TTM)-16.3436

% RANGE6.19%

EPS(TTM)-0.1909

P/E(FORWARD)37.43

P/B1.876

BVPS1.664

DIVIDEND--

P/S1.048

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP26.15M

SHARES OUTSTANDING14.96M

NEXT EARNINGS05/04-05/08

FREE FLOAT8.38M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·03/17 13:21
Cumberland announces launch of new Sancuso website
PR Newswire·03/17 13:05
Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting
NASDAQ·03/10 17:49
Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales
Reuters·03/09 21:03
Cumberland Pharmaceuticals Inc. Announces Annual Shareholder Meeting
Seeking Alpha·03/04 00:33
Cumberland targets double-digit revenue growth in 2026 as Talicia and Vibativ fuel expansion
NASDAQ·03/03 22:45
Cumberland (CPIX) Q4 2025 Earnings Call Transcript
Reuters·03/03 22:12
Cumberland Pharmaceuticals 2025 revenue rises
Seeking Alpha·03/03 22:11
Cumberland Pharmaceuticals Non-GAAP EPS of $0.11, revenue of $44.5M
Dow Jones·03/03 22:01
*CUMBERLAND PHARMACEUTICALS REPORTS 31% 4Q 2025 Rev GROWTH
Dow Jones·03/03 22:01
*Cumberland Pharma 4Q Rev $13.7M >CPIX
Reuters·03/03 22:00
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH
Dow Jones·03/03 22:00
*Cumberland Pharma 4Q Loss/Shr 9c >CPIX
Dow Jones·03/03 22:00
Press Release: CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH
Dow Jones·03/03 22:00
Press Release: CUMBERLAND PHARMACEUTICALS REPORTS -4-

Same Industry

Name/Symbol

Change%

Price

CPIX

McKesson

MCK

-0.39%

860.16

Biogen Inc

BIIB

-3.78%

183.84

AMGN

Shire

SHPG

0.00%

179.20

CELG-RT

Lilly Eli & Co

LLY

+0.96%

886.63

CELG

TXMD

Johnson & Johnson

JNJ

+0.51%

240.45

Abbvie Inc

ABBV

+1.78%

213.12

ZTS

GILD

Novo-Nordisk A/S

NVO

-0.99%

36.04

Bristol-Myers Squibb Co

BMY

-1.50%

58.54

ALXN

Pfizer

PFE

+2.70%

27.77

Sanofi FR

SNY

+0.34%

46.78

GCVRZ

NVS

Dr Reddys Labs

RDY

-2.11%

13.48

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.